Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study
Options
Publisher DOI
PubMed ID
21036880
Description
It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma. This study assesses the safety and tolerability of a continuous regimen of sorafenib combined with TACE.
Date of Publication
2010
Publication Type
Article
Language(s)
en
Contributor(s)
Heim, Markus H | |
Helbling, Beat | |
Maurhofer, Olivier | |
Series
Oncologist
Publisher
AlphaMed Press
ISSN
1083-7159
Access(Rights)
metadata.only